Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$100.73 - $112.44 $3,727 - $4,160
-37 Reduced 1.65%
2,201 $228,000
Q1 2024

May 13, 2024

BUY
$109.52 - $120.96 $4,599 - $5,080
42 Added 1.91%
2,238 $254,000
Q4 2023

Feb 12, 2024

BUY
$90.19 - $110.4 $198,057 - $242,438
2,196 New
2,196 $241,000
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $140,737 - $165,656
-1,453 Reduced 38.33%
2,338 $236,000
Q4 2022

Feb 08, 2023

BUY
$95.06 - $111.52 $134,414 - $157,689
1,414 Added 59.49%
3,791 $416,000
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $2,806 - $3,248
-29 Reduced 1.21%
2,377 $229,000
Q2 2022

Aug 04, 2022

SELL
$102.07 - $123.37 $367,247 - $443,885
-3,598 Reduced 59.93%
2,406 $261,000
Q1 2022

May 12, 2022

BUY
$114.02 - $139.04 $102,275 - $124,718
897 Added 17.56%
6,004 $713,000
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $415,099 - $508,265
3,593 Added 237.32%
5,107 $709,000
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $176,623 - $195,396
1,514 New
1,514 $178,000
Q3 2017

Nov 13, 2017

SELL
$48.06 - $53.64 $646,743 - $721,833
-13,457 Closed
0 $0
Q2 2017

Aug 09, 2017

BUY
N/A
13,457
13,457 $649,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Gerber Kawasaki Wealth & Investment Management Portfolio

Follow Gerber Kawasaki Wealth & Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gerber Kawasaki Wealth & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Gerber Kawasaki Wealth & Investment Management with notifications on news.